Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries (LEVANT China)

NCT02720003 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.

NCT NCT02720003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02720003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries (LEVANT China)
Lead sponsor
C. R. Bard
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2016
Completion date
August 31, 2020
Enrollment
148 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

femoral artery occlusion, femoral artery stenosis, occlusion of popliteal arteries, stenosis of popliteal arteries